These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37407242)

  • 21. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
    Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
    mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
    Doustdar F; Khosravi AD; Farnia P
    Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Mutations in
    Shrestha D; Maharjan B; Thapa J; Akapelwa ML; Bwalya P; Chizimu JY; Nakajima C; Suzuki Y
    Curr Issues Mol Biol; 2022 Sep; 44(9):4132-4141. PubMed ID: 36135195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant
    Shi J; Su R; Zheng D; Zhu Y; Ma X; Wang S; Li H; Sun D
    Infect Drug Resist; 2020; 13():2929-2941. PubMed ID: 32903869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
    Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C
    Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of
    Li K; Yang Z; Gu J; Luo M; Deng J; Chen Y
    Front Microbiol; 2020; 11():594171. PubMed ID: 33505367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
    Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
    Bouzouita I; Cabibbe AM; Trovato A; Draoui H; Ghariani A; Midouni B; Essalah L; Mehiri E; Cirillo DM; Slim-Saidi L
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):661-666. PubMed ID: 29862951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
    Lee KW; Lee JM; Jung KS
    J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.
    Louw GE; Warren RM; Donald PR; Murray MB; Bosman M; Van Helden PD; Young DB; Victor TC
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):802-7. PubMed ID: 16848344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.
    McCammon MT; Gillette JS; Thomas DP; Ramaswamy SV; Rosas II; Graviss EA; Vijg J; Quitugua TN
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2210-7. PubMed ID: 15917514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.
    Hirano K; Takahashi M; Kazumi Y; Fukasawa Y; Abe C
    Tuber Lung Dis; 1997; 78(2):117-22. PubMed ID: 9692180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
    Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
    Xia Q; Zhao LL; Li F; Fan YM; Chen YY; Wu BB; Liu ZW; Pan AZ; Zhu M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1690-5. PubMed ID: 25583712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
    Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH
    BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.
    Driesen M; Kondo Y; de Jong BC; Torrea G; Asnong S; Desmaretz C; Mostofa KSM; Tahseen S; Whitfield MG; Cirillo DM; Miotto P; Cabibbe AM; Rigouts L
    Clin Microbiol Infect; 2018 Jan; 24(1):60-64. PubMed ID: 28587904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.